Thank you This live web event has ended. Thank you for attending. Contributors Christopher Worrall, Ph.D. Dr. Christopher Worrall obtained his Ph.D. in synthetic organic chemistry from the University of Manchester, UK, and has multiple publications in the areas of atropisomerism and enantioselective synthesis. After his studies he spent two years developing synthetic processes for GMP syntheses within SAFC before moving to Pharmorphix. Subsequently, Chris has spent 13 years specializing in the area of crystallization and physicochemical modification, starting as a scientist before being promoted to project leader and rising to become US business development manager. Chris has been involved in the development of 5 commercial pharmaceutical products and is an inventor on patents in the areas of liquid crystals, organic semi-conductors and pharmaceutical solid form. A native of North West England, Chris has spent the last 9 years in San Diego – where the weather is significantly better – and in May this year became the Vice President of US Business Development for Nanoform.